Vimarsana
Biggest News Aggregation in the World

Fontus Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fontus Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fontus Capital Today - Breaking & Trending Today

Chinese biotech firm Varnotech snaps $84m Series B funding - Vimarsana News

Chinese biotech firm Varnotech snaps $84m Series B funding

Vaccine developer Varnotech has secure 600 million yuan ($84 million) in a Series B funding round.

Jura Bio Raises $16.1M in Financing - Vimarsana News

Jura Bio Raises $16.1M in Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

3 lessons from September's 3 big IPOs - Vimarsana News

3 lessons from September's 3 big IPOs

The meager post-IPO performance of Arm, Instacart, and Klaviyo means that “the first half of 2024 is the new second half of 2023” for other IPO hopefuls, according to Renaissance Capital’s Matthew Kennedy.

Temasek co-leads $35m pre-Series B round in China's Lupeng Pharma - Vimarsana News

Temasek co-leads $35m pre-Series B round in China's Lupeng Pharma

Kaitai Capital was the other lead investor in the round.

China Digest: Rona Therapeutics bags $33m; Singleron buys SG's Proteona - Vimarsana News

China Digest: Rona Therapeutics bags $33m; Singleron buys SG's Proteona

Proteona is a precision medicine company offering single-cell biomarker discovery services to translational and clinical researchers.